The results revealed that MAP3K8 overexpression was correlated with damaged survival in ccRCC, reemphasizing the potential for identifying predictive biomarkers and therapeutic targets focused on MAP3K8 and MAPK pathway. This evidence concerns the gene MAP3K8 and nonpapillary renal cell carcinoma.